622 filings
PRE 14A
PVCT
Provectus Biopharmaceuticals, Inc.
Preliminary proxy
26 Apr 24
11:48am
8-K
PVCT
Provectus Biopharmaceuticals, Inc.
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
10-K
2023 FY
PVCT
Provectus Biopharmaceuticals, Inc.
Annual report
28 Mar 24
2:35pm
8-K
PVCT
Provectus Biopharmaceuticals, Inc.
27 Mar 24
Entry into a Material Definitive Agreement
12:10pm
8-K
PVCT
Provectus Biopharmaceuticals, Inc.
26 Mar 24
Departure of Directors or Certain Officers
4:48pm
8-K
oyeihq
22 Feb 24
Regulation FD Disclosure
9:30am
8-K
7e0tkf
15 Feb 24
Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
8:05am
8-K
nfluw
22 Jun 23
Submission of Matters to a Vote of Security Holders
12:00am
8-K
iwpqj18bhkqw
21 Jun 23
Regulation FD Disclosure
9:50am
DEFA14A
nkulgvocw n3398gaf
21 Jun 23
Additional proxy soliciting materials
9:45am
ARS
pc2jy7gno
11 May 23
Annual report to shareholders
3:18pm
DEFA14A
l27grm6516g2nb5jx
1 May 23
Additional proxy soliciting materials
2:01pm
8-K
5ntnmuiurrx
17 Apr 23
Regulation FD Disclosure
9:00am
8-K
l3c4x5bk xd2akn
9 Jan 23
Regulation FD Disclosure
7:00am